CONSUMER DEFENSIVE · NYSE/NASDAQ: CL

COLGATE PALMOLIVE CO Earnings Summary — Q1 2026

Sentiment: Neutral
AI-generated summary
Generated 2026-06-25

Colgate-Palmolive Delivers Strong 8.4% Revenue Growth in Q1 2026 Despite Net Profit Pressure

Net Profit
$5.32B
YoY -6.58%
Comparison based on Q1 2026 vs Q1 2025 (726) and Q1 2024 (729) · Reconciled from narrative (was 681)
Revenue
$5.32B
YoY 8.41%
QoQ 1.80%
Prior: $4.91B
Operating Margin
18.11%
YoY -3.80%
QoQ 16.35%
Prior: 21.91%
Dividend Yield
Net Debt / Equity
Balance sheet equity levels are volatile due to treasury stock programs

Key Takeaways

  • Revenue reached a multi-quarter high of $5.32 billion, representing 8.41% year-over-year growth.
  • Net income attributable to common shareholders was $646 million, down from $690 million in the prior year quarter.
  • Operating income recovered significantly to $964 million from a depressed $92 million in Q4 2025.
  • Selling, General & Administrative expenses rose to $2.08 billion, indicating continued investment in brand support.
  • The company continues to reduce its shares outstanding, down 1.21% year-over-year to 802 million basic shares.
  • Gross profit margins remain robust at 60.6%, benefiting from strong pricing power in core categories.
  • Hill's Pet Nutrition and premium oral care remain key strategic growth diversifiers for the portfolio.

Management Guidance

Management remains focused on productivity programs and digital transformation to protect margins against inflationary pressures and currency headwinds.

Sentiment Shift

Stable

While revenue growth is accelerating, net profit has seen a year-over-year decline due to higher operating and non-operating expenses.

Resilient
Growth-Oriented
Cost-Conscious

Outlook

The company is positioned as a high-quality compounder with dominant market share in oral care (~40%) and strong cash flow generation, despite a thin equity base from aggressive capital returns.

From the Annual Report (Key Quotes)

The ability to push through price increases in core categories without sacrificing significant volume speaks to strong brand equity.

Strategic shift toward 'Hill's Pet Nutrition' and premium oral care products has successfully diversified the growth profile.

The core business remains a cash generative engine with a highly resilient competitive position.

Earnings Call Transcript — Q1 2026

Transcript is fetched on demand to save crawl credits. Click below to load the latest earnings call transcript for this quarter.

This summary is AI-generated from COLGATE PALMOLIVE CO's latest quarterly filing and earnings call. For informational purposes only — not investment advice.

← Back to COLGATE PALMOLIVE CO AI analysis